FBIO logo

Fortress Biotech (FBIO)

Profile

Full Name

Fortress Biotech, Inc.

Ticker Symbol

FBIO

Exchange

NASDAQ

Country

United States

IPO

November 17, 2011

Indexes

Not included

Employees

101

Key Details

Price

$1.46(+3.55%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$57.67M(-31.76% YoY)

Annual EPS

-$2.69(+68.24% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 11, 25 Roth MKM
Buy
Nov 18, 24 HC Wainwright & Co.
Buy
Jul 19, 24 HC Wainwright & Co.
Buy
Jun 20, 24 Cantor Fitzgerald
Overweight
May 16, 24 Roth MKM
Buy
Mar 19, 24 Alliance Global Partners
Buy
Nov 29, 23 Roth MKM
Buy
Aug 15, 23 Cantor Fitzgerald
Overweight
May 16, 23 Cantor Fitzgerald
Overweight
Apr 6, 23 Benchmark
Speculative Buy

Institutional Ownership

  • What is the ticker symbol for Fortress Biotech?
  • Does Fortress Biotech pay dividends?
  • What sector is Fortress Biotech in?
  • What industry is Fortress Biotech in?
  • What country is Fortress Biotech based in?
  • When did Fortress Biotech go public?
  • Is Fortress Biotech in the S&P 500?
  • Is Fortress Biotech in the NASDAQ 100?
  • Is Fortress Biotech in the Dow Jones?
  • When was Fortress Biotech's last earnings report?
  • When does Fortress Biotech report earnings?
  • Should I buy Fortress Biotech stock now?

What is the ticker symbol for Fortress Biotech?

The ticker symbol for Fortress Biotech is NASDAQ:FBIO

Does Fortress Biotech pay dividends?

No, Fortress Biotech does not pay dividends

What sector is Fortress Biotech in?

Fortress Biotech is in the Healthcare sector

What industry is Fortress Biotech in?

Fortress Biotech is in the Biotechnology industry

What country is Fortress Biotech based in?

Fortress Biotech is headquartered in United States

When did Fortress Biotech go public?

Fortress Biotech's initial public offering (IPO) was on November 17, 2011

Is Fortress Biotech in the S&P 500?

No, Fortress Biotech is not included in the S&P 500 index

Is Fortress Biotech in the NASDAQ 100?

No, Fortress Biotech is not included in the NASDAQ 100 index

Is Fortress Biotech in the Dow Jones?

No, Fortress Biotech is not included in the Dow Jones index

When was Fortress Biotech's last earnings report?

Fortress Biotech's most recent earnings report was on Mar 26, 2025

When does Fortress Biotech report earnings?

The next expected earnings date for Fortress Biotech is May 15, 2025

Should I buy Fortress Biotech stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page